lymph node

淋巴结
  • 文章类型: Journal Article
    背景:宫颈癌是女性第四常见的癌症,死亡率最高的是低收入和中等收入国家。宫颈癌的腹部顶叶转移是一种非常罕见的实体,发病率为0.1-1.3%,并代表一个不利的预后因素,生存率降至17%。这里,我们回顾了近几十年来腹部顶叶转移的病例,包括在诊断为IIB期宫颈癌(腺鳞癌)28个月后,在前引流管的疤痕部位出现4.5厘米的腹部顶叶转移的新病例,同时进行化疗和腔内近距离放射治疗以及随后的手术(B型根治性子宫切除术)。肿瘤在肿瘤范围内切除,组织病理学结果为腺鳞癌。该案例研究强调了早期发现和适当治疗宫颈癌患者转移的重要性。讨论探讨了壁转移的潜在途径以及不完整的外科手术对转移发展的影响。结论强调了宫颈癌患者与此类转移相关的不良预后,以及手术切除与全身治疗相关的潜在益处。
    BACKGROUND: Cervical cancer is the fourth most common cancer in women, the highest mortality being found in low- and middle-income countries. Abdominal parietal metastases in cervical cancer are a very rare entity, with an incidence of 0.1-1.3%, and represent an unfavorable prognostic factor with the survival rate falling to 17%. Here, we present a review of cases of abdominal parietal metastasis in recent decades, including a new case of a 4.5 cm abdominal parietal metastasis at the site of the scar of the former drain tube 28 months after diagnosis of stage IIB cervical cancer (adenosquamous carcinoma), treated by external radiotherapy with concurrent chemotherapy and intracavitary brachytherapy and subsequent surgery (type B radical hysterectomy). The tumor was resected within oncological limits with the histopathological result of adenosquamous carcinoma. The case study highlights the importance of early detection and appropriate treatment of metastases in patients with cervical cancer. The discussion explores the potential pathways for parietal metastasis and the impact of incomplete surgical procedures on the development of metastases. The conclusion emphasizes the poor prognosis associated with this type of metastasis in cervical cancer patients and the potential benefits of surgical resection associated with systemic therapy in improving survival rates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景和目的:宫颈癌是女性中第四常见的肿瘤类型。最常见的是由人乳头瘤病毒(hrHPV)的高风险链持续感染引起。当常规HPV筛查开始时,其发病率从25岁开始迅速增加,然后在45岁时降低。这反映了首次筛查时对流行病例的诊断以及成年早期HPV暴露的可能高峰。对于早期阶段,该治疗提供了保留生育能力的可能性。.然而,在更先进的阶段,治疗仅限于伴随的放化疗,合并,在非常选定的病例中进行手术干预。新辅助治疗后,对患者进行想象的重新评估,以分析疾病的阶段是否保持不变或降低分期。新辅助治疗后淋巴结降级被认为是预测晚期宫颈癌患者疾病复发和生存的可靠预后因素。这项研究旨在确定放射治疗在疾病分期降低和淋巴结清扫术在控制晚期宫颈癌患者淋巴结浸润中的重要生存作用。材料和方法:我们描述了在布加勒斯特肿瘤研究所治疗的IIIC1FIGO期宫颈癌患者的预后。所有患者均接受放疗,三分之二同时接受化疗。新辅助治疗结束后6至8周,进行了C型根治性子宫切除术和根治性盆腔淋巴结清扫术。结果:McNemar试验显示新辅助治疗后淋巴结病变消退,p:<0.001。然而,腺病的持久性与照射剂量无关(p:0.61),放射治疗次数(p:0.80),或化疗(p:0.44)。此外,通过想象方法报告的腺病与手术干预期间确定的腺病之间没有显着差异-p:0.62.使用Kaplan-Meier曲线评估的总生存期取决于放疗后FIGO阶段-p:0.002和手术干预期间评估的淋巴结状态-p:0.04。与死亡风险增加相关的危险因素表现为术前血红蛋白水平低(p:0.003)和手术干预期间确定的晚期FIGO阶段(p值:IIIA期为0.006,IIIC1期为0.01)。在多元Cox模型中,生存的独立预测因子为术前血红蛋白水平(p:0.004,HR0.535,CI:0.347~0.823).在总共33例接受新辅助治疗的患者中,22人存活到研究结束,所有33人对治疗都有不同程度的反应,但是在其中三个中,术中组织病理学检查在淋巴结中发现肿瘤细胞。结论:对于晚期宫颈癌患者,新辅助治疗后的根治性手术可能与更好的生存率相关。需要进一步的研究来确定导致某些患者腺病持续存在的所有原因,为了减少手术干预后的FIGO阶段,and,因此,降低死亡风险。此外,必须正确评估和治疗贫血,因为它似乎是死亡率的独立预测因素。
    Background and Objectives: Cervical cancer is the fourth most frequent type of neoplasia in women. It is most commonly caused by the persistent infection with high-risk strands of human papillomavirus (hrHPV). Its incidence increases rapidly from age 25 when routine HPV screening starts and then decreases at the age of 45. This reflects both the diagnosis of prevalent cases at first-time screening and the likely peak of HPV exposure in early adulthood. For early stages, the treatment offers the possibility of fertility preservation.. However, in more advanced stages, the treatment is restricted to concomitant chemo-radiotherapy, combined, in very selected cases with surgical intervention. After the neoadjuvant treatment, an imagistic re-evaluation of the patients is carried out to analyze if the stage of the disease remained the same or suffered a downstaging. Lymph node downstaging following neoadjuvant treatment is regarded as an indubitable prognostic factor for predicting disease recurrence and survival in patients with advanced cervical cancer. This study aims to ascertain the important survival role of radiotherapy in the downstaging of the disease and of lymphadenectomy in the control of lymph node invasion for patients with advanced-stage cervical cancer. Material and Methods: We describe the outcome of patients with cervical cancer in stage IIIC1 FIGO treated at Bucharest Oncological Institute. All patients received radiotherapy and two-thirds received concomitant chemotherapy. A surgical intervention consisting of type C radical hysterectomy with radical pelvic lymphadenectomy was performed six to eight weeks after the end of the neoadjuvant treatment. Results: The McNemar test demonstrated the regression of lymphadenopathies after neoadjuvant treatment-p: <0.001. However, the persistence of adenopathies was not related to the dose of irradiation (p: 0.61), the number of sessions of radiotherapy (p: 0.80), or the chemotherapy (p: 0.44). Also, there were no significant differences between the adenopathies reported by imagistic methods and those identified during surgical intervention-p: 0.62. The overall survival evaluated using Kaplan-Meier curves is dependent on the post-radiotherapy FIGO stage-p: 0.002 and on the lymph node status evaluated during surgical intervention-p: 0.04. The risk factors associated with an increased risk of death were represented by a low preoperative hemoglobin level (p: 0.003) and by the advanced FIGO stage determined during surgical intervention (p-value: 0.006 for stage IIIA and 0.01 for stage IIIC1). In the multivariate Cox model, the independent predictor of survival was the preoperative hemoglobin level (p: 0.004, HR 0.535, CI: 0.347 to 0.823). Out of a total of 33 patients with neoadjuvant treatment, 22 survived until the end of the study, all 33 responded to the treatment in varying degrees, but in 3 of them, tumor cells were found in the lymph nodes during the intraoperative histopathological examination. Conclusions: For advanced cervical cancer patients, radical surgery after neoadjuvant treatment may be associated with a better survival rate. Further research is needed to identify all the causes that lead to the persistence of adenopathies in certain patients, to decrease the FIGO stage after surgical intervention, and, therefore, to lower the risk of death. Also, it is mandatory to correctly evaluate and treat the anemia, as it seems to be an independent predictor factor for mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:评估肝门淋巴结(PHLNs)在超声(US)扫描中诊断胆道闭锁(BA)和预测Kasai门肠造口术(KPE)术后结局的有用性。
    方法:一家医院共668名患者纳入研究(542名非BA和126BA)。PHLN的独立和联合诊断效能,三角线(TC)厚度,通过绘制受试者工作特征(ROC)曲线并计数ROC曲线下面积(AUC)来评估胆囊形态,灵敏度,特异性,阳性预测值(PPV),和阴性预测值(NPV)。美国的特点,PHLNs的组织病理学发现,与KPE后3个月血清总胆红素(TBIL)水平相关。
    结果:AUC,灵敏度,特异性,PPV,具有高回声性和最大长度大于8.4mm的PHLN的NPV分别为0.898,81.8%,97.8%,89.6%,和95.8%,分别。PHLN的组合,TC厚度,胆囊形态学在所有指标中取得了最佳的总体诊断效能,AUC为0.927,灵敏度为99.2%。PHLN的生发中心数和胆汁颗粒数与PHLN的病理大小和US回声强度呈正相关。(r=0.591,0.377,p=0.001,0.004)。BA患者术后3个月的PHLN病理大小与黄疸清除状态呈负相关(r=-0.385,p=0.047)。
    结论:具有高回声性和最大长度>8.4mm的PHLN是用于BA诊断的有用的US指标。此外,PHLN的扩大可能在预测KPE手术结局方面发挥作用.
    文章首次提出了具有高回声性和最大长度>8.4mm的PHLN是诊断BA的有用的美国指标。
    结论:PHLNs可能有助于诊断BA和预测术后结局。扩大的高回声PHLN是BA的有用诊断指标,并在预测手术结果方面发挥作用。这些发现可以帮助临床医生更准确地诊断BA,使更及时的治疗。
    OBJECTIVE: To evaluate the usefulness of porta hepatis lymph nodes (PHLNs) on ultrasonography (US) scans in diagnosing biliary atresia (BA) and predicting the outcomes after Kasai portoenterostomy (KPE) surgery.
    METHODS: A total of 668 patients from one hospital were enrolled in the study (542 non-BA and 126 BA). The independent and combined diagnostic efficacy of PHLNs, triangular cord (TC) thickness, and gallbladder morphology were assessed by drawing the receiver operating characteristic (ROC) curves and counting the area under the ROC curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The US features, histopathological findings of PHLNs, and serum total bilirubin (TBIL) levels 3 months post-KPE were correlated.
    RESULTS: The AUC, sensitivity, specificity, PPV, and NPV of PHLNs with hyperechogenicity and a maximum length larger than 8.4 mm were 0.898, 81.8%, 97.8%, 89.6%, and 95.8%, respectively. The combination of PHLNs, TC thickness, and gallbladder morphology achieved the best overall diagnostic efficacy among all indicators with an AUC of 0.927 and a sensitivity of 99.2%. The germinal center number and bile particle number of PHLNs were positively correlated with pathological size and US echogenicity intensity of PHLNs, respectively (r = 0.591, 0.377, p = 0.001, 0.004). The pathological size of PHLNs in BA patients was negatively correlated with jaundice clearance status 3 months after KPE surgery (r = -0.385, p = 0.047).
    CONCLUSIONS: PHLNs with hyperechogenicity and a maximum length > 8.4 mm are useful US indicators for BA diagnosis. Additionally, the enlargement of PHLNs might play a role in predicting outcomes of KPE surgery.
    UNASSIGNED: The article proposed for the first time that PHLNs with hyperechogenicity and a maximum length > 8.4 mm are a useful US indicator for diagnosing BA.
    CONCLUSIONS: PHLNs may be helpful in diagnosing BA and predicting outcomes after surgery. Enlarged hyperechoic PHLNs are a useful diagnostic indicator for BA, and play a role in predicting surgical outcomes. These findings can assist clinicians in more accurately diagnosing BA, enabling more timely treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:间变性甲状腺癌(ATC)是甲状腺恶性肿瘤的一种罕见病理类型。原发性甲状腺鳞状细胞癌(PSCCT)现在被认为是ATC的一种亚型,以下简称ATC-SCC亚型。ATC-SCC亚型合并滤泡性甲状腺癌极为罕见,报告的病例较少。ATC-SCC亚型是一种高侵袭性肿瘤,转移后患者预后差,目前这种类型的肿瘤的治疗是棘手的。
    方法:一名68岁女性患者表现为右宫颈区域逐渐肿胀。综合辅助检查和术后病理证实ATC-SCC亚型诊断为甲状腺滤泡状癌,右颈淋巴结转移鳞状细胞癌起源于ATC-SCC亚型。患者术后接受放化疗。然而,姑息性切除术后,残留的颈淋巴结转移伴鳞状细胞癌仍广泛浸润颈部周围结构。患者术后7个月死亡。
    结论:我们的病例强调颈淋巴结转移可能是ATC-SCC亚型预后不良的重要因素。这种恶性肿瘤应及早发现和治疗。
    BACKGROUND: Anaplastic thyroid carcinoma(ATC) is a rare pathological type of thyroid malignancy. Primary squamous cell carcinoma of thyroid(PSCCT) is now considered as a subtype of ATC, hereinafter referred to as ATC-SCC subtype. ATC-SCC subtype combined with follicular thyroid carcinoma is exceedingly rare, with fewer cases reported. The ATC-SCC subtype is a highly invasive tumor with a poor prognosis for patients after metastasis occurs, and current treatment of this type of tumor is tricky.
    METHODS: A 68-year-old female patient presented with a gradually growing swelling of right cervical region. Comprehensive auxiliary examinations and postoperative pathology confirmed the diagnosis of ATC-SCC subtype with follicular thyroid carcinoma, and the metastasis squamous cell carcinoma of the right cervical lymph nodes originates from ATC-SCC subtype. The patient received chemoradiotherapy postoperative. However, the residual cervical lymph nodes metastasis with squamous cell carcinoma still infiltrated surrounding structures in the neck extensively after palliative resection. The patient died 7 months after surgery.
    CONCLUSIONS: Our case highlights that cervical lymph node metastasis may be a significant factor in the poor prognosis of ATC-SCC subtype. This malignancy should be detected and treated early.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:为了比较Node-RADS评分系统和淋巴结(LN)大小在直肠癌(RC)的术前LN评估中的诊断性能,并研究选择大小作为主要标准,而形态学作为LN的次要标准是否可以被认为是临床评估的首选方法。
    方法:对146例接受根治性手术治疗的RC患者的术前CT资料进行回顾性分析。获得尺寸优先的LN和形态优先的LN的Node-RADS评分和短轴直径。Node-RADS评分与pN阶段的相关性,研究了LNM数量和淋巴结比率(LNR)。比较了Node-RADS评分和短轴直径在评估病理淋巴结转移方面的表现。还评估了结合Node-RADS评分和临床特征的列线图。
    结果:Node-RADS评分与pN分期显著相关,LNM数和LNR(大小优先LN的节点-RADS:r=0.600、0.592和0.606;形态优先LN的节点-RADS:r=0.547、0.538和0.527;节点-RADSmax:r=0.612、0.604和0.610;所有p<0.001)。对于按大小优先排序的LN,Node-RADS的AUC为0.826,明显优于短轴直径(0.826vs.0.743,p=0.009)。对于形态学优先的LN,Node-RADS的AUC为0.758,略优于短轴直径(0.758vs.0.718,p=0.098)。大小优先LN的Node-RADS评分明显优于形态优先LN(0.826vs.0.758,p=0.038)。与所有其他评估方法相比,列线图取得了最好的诊断性能(AUC=0.861)(p<0.05)。
    结论:Node-RADS评分系统在预测RC淋巴结转移方面优于短轴直径。与形态学优先的LN相比,尺寸优先的LN表现出更好的预测功效。将大小优先的LN的Node-RADS评分与临床特征相结合的列线图表现出最佳的诊断性能。此外,Node-RADS评分与LNM的数量依赖性病理特征之间有明确的关系.
    BACKGROUND: To compare the diagnostic performance of the Node-RADS scoring system and lymph node (LN) size in preoperative LN assessment for rectal cancer (RC), and to investigate whether the selection of size as the primary criterion whereas morphology as the secondary criterion for LNs can be considered the preferred method for clinical assessment.
    METHODS: Preoperative CT data of 146 RC patients treated with radical resection surgery were retrospectively analyzed. The Node-RADS score and short-axis diameter of size-prioritized LNs and the morphology-prioritized LNs were obtained. The correlations of Node-RADS score to the pN stage, LNM number and lymph node ratio (LNR) were investigated. The performances on assessing pathological lymph node metastasis were compared between Node-RADS score and short-axis diameter. A nomogram combined the Node-RADS score and clinical features was also evaluated.
    RESULTS: Node-RADS score showed significant correlation with pN stage, LNM number and LNR (Node-RADS of size-prioritized LN: r = 0.600, 0.592, and 0.606; Node-RADS of morphology-prioritized LN: r = 0.547, 0.538, and 0.527; Node-RADSmax: r = 0.612, 0.604, and 0.610; all p < 0.001). For size-prioritized LN, Node-RADS achieved an AUC of 0.826, significantly superior to short-axis diameter (0.826 vs. 0.743, p = 0.009). For morphology-prioritized LN, Node-RADS exhibited an AUC of 0.758, slightly better than short-axis diameter (0.758 vs. 0.718, p = 0.098). The Node-RADS score of size-prioritized LN was significantly better than that of morphology-prioritized LN (0.826 vs. 0.758, p = 0.038). The nomogram achieved the best diagnostic performance (AUC = 0.861) than all the other assessment methods (p < 0.05).
    CONCLUSIONS: The Node-RADS scoring system outperforms the short-axis diameter in predicting lymph node metastasis in RC. Size-prioritized LN demonstrates superior predictive efficacy compared to morphology-prioritized LN. The nomogram combined the Node-RADS score of size-prioritized LN with clinical features exhibits the best diagnostic performance. Moreover, a clear relationship was demonstrated between the Node-RADS score and the quantity-dependent pathological characteristics of LNM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    肿瘤内部乳头状结构的存在是乳腺癌的一个独特且不常见的特征,它被称为乳头状癌。与其他形式的乳腺癌相比,这种变异通常在影像学检查中表现为明确的肿块,并且通常与良好的预后相关.我们介绍了一例72岁女性,其乳腺乳头状癌在出现明显的乳腺肿块后被发现。在进行了左乳房简单切除术和辅助治疗后,组织病理学研究证实了肿瘤内部存在乳头状结构.了解乳腺乳头状癌的临床和病理特征对于准确诊断和制定合适的治疗策略至关重要。需要更多的研究来进一步了解治疗这种罕见的乳腺癌亚型的分子特征和最佳实践。
    The presence of papillary structures inside the tumor is a unique and uncommon characteristic of breast cancer, and it is known as papillary carcinoma. In contrast to other forms of breast cancer, this variant usually manifests as a well-defined mass in imaging investigations and is frequently linked to a good prognosis. We present a case of a 72-year-old female with papillary carcinoma of the breast identified after presenting with a palpable breast lump. Following a left simple mastectomy and adjuvant treatment, the presence of papillary structures inside the tumor was verified by a histopathological study. Understanding the clinical and pathological characteristics of breast papillary carcinoma is crucial for precise diagnosis and suitable therapy strategizing. More research is required to further understand the molecular traits and best practices for treating this uncommon subtype of breast cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    卵巢癌通常局限于腹膜内。出现时远处转移是不寻常的。它通过淋巴管传播并不常见,腋窝淋巴结转移非常罕见。我们报告了2例无乳腺受累的腋窝淋巴结病。计算机断层扫描确定了卵巢肿块。两者都有升高的血清Ca125。第一例为2级卵巢子宫内膜样癌。第二例患有高级别浆液性卵巢癌。这些病例说明了卵巢癌腋窝淋巴结病的罕见性。为了提供适当的治疗,确定原发性卵巢癌很重要。尽管手术和化疗,两者都在诊断后3年内死亡。
    Ovarian cancer is usually confined intraperitoneally. Distant metastases at presentation is unusual. Its spread via lymphatics is uncommon, and metastasis to axillary lymph nodes is very rare. We report two cases with presentation of axillary lymphadenopathy without breast involvement. Computed tomography scan identified the ovarian masses. Both had elevated Serum Ca 125. The first case had a Grade 2 ovarian endometrioid carcinoma. The second case had a high-grade serous ovarian carcinoma. These cases illustrate the rarity of axillary lymphadenopathy from ovarian cancer. It is important to identify the primary ovarian carcinoma in order to offer appropriate management. Despite surgery and chemotherapy, both succumbed within 3 years from diagnosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    甲状腺乳头状癌(PTC)的淋巴结转移已成为甲状腺疾病研究中非常感兴趣的领域。本研究旨在通过全面的文献计量分析,阐明PTC淋巴结转移在甲状腺疾病研究中的研究趋势和影响。
    我们使用WebofScience核心数据库(WOSCC)对PTC淋巴结转移的文献进行了广泛的文献计量学综述,其中包括2012年至2022年的约3292份出版物。进行了数据分析和可视化,使用先进的文献计量工具,包括VOSviewer,CiteSpace,和BibliometrixR软件包。
    共确定了来自81个国家的3292种出版物。分析显示,从2012年到2022年,每年的出版物数量呈增长模式,其中中国的论文数量最多。中国做出了杰出贡献,韩国,美国,意大利和日本,甲状腺是最重要的杂志.发表论文最多的作者是朱景强。发表论文最多的机构是上海交通大学和延世大学。分析发现,预后,复发,和超声是除与本文标题相关的关键词外,出现频率最高的关键词。
    我们的文献计量学分析概述了PTC淋巴结转移的研究现状,强调重大贡献,趋势,以及未来的研究方向。
    UNASSIGNED: Lymph node metastasis in papillary thyroid carcinoma (PTC) has become an area of great interest in the study of thyroid diseases. The aim of this study was to elucidate the research trends and impact of lymph node metastasis of PTC in the study of thyroid diseases through a comprehensive bibliometric analysis.
    UNASSIGNED: We conducted an extensive bibliometric review of the literature on lymph node metastasis in PTC using the Web of Science Core Database (WOSCC), which included approximately 3292 publications from 2012 to 2022. Data analysis and visualization were performed, using advanced bibliometric tools including VOSviewer, CiteSpace, and bibliometrix R software packages.
    UNASSIGNED: A total of 3292 publications from 81 one countries were identified. The analysis showed a pattern of growth in the number of publications per year from 2012 to 2022, with China having the highest number of papers. Outstanding contributions were made by China, Korea, USA, Italy and Japan, with Thyroid being the most important journal. The author who published the most papers was Jingqiang Zhu. The institutions that published the most papers were Shanghai Jiao Tong University and Yonsei University. The analysis found that prognosis, recurrence, and ultrasound were the keywords with the highest frequency of occurrence in addition to those related to the title of this article.
    UNASSIGNED: Our bibliometric analysis outlines the current state of research on lymph node metastasis in PTC, highlighting significant contributions, trends, and future research directions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    开发并验证用于术前预测进行性肌层浸润性膀胱癌患者淋巴结转移的列线图。
    我们回顾性招募了患者,将他们分为培训和验证队列,收集病人的人口统计数据,经尿道膀胱肿瘤切除术标本的病理资料,影像学发现,实验室信息。我们进行了逻辑回归分析,单变量和多变量,调查独立的术前风险变量并建立列线图。进行内部和外部验证以评估该列线图的预测性能。
    训练队列由144名晚期肌层浸润性膀胱癌患者组成,而验证队列包括62名个体。术前独立危险因素为肿瘤病理分级,血小板计数,影像学上的肿瘤大小,淋巴结大小,用于开发列线图。该模型表现出很高的预测精度,如主要和外部验证队列的受试者工作特征曲线下面积值0.898和0.843所证明的那样,分别。校准曲线和决策曲线分析显示两个队列的列线图表现良好,表明其具有较高的临床适用性。
    成功开发了用于术前预测晚期肌层浸润性膀胱癌患者淋巴结转移的列线图;其准确性,可靠性,并证明了临床价值。这种新工具将有助于在根治性膀胱切除术中是否进行完整淋巴结清扫的临床决策。
    UNASSIGNED: To develop and validate a nomogram for preoperative prediction of lymph node metastasis in patients with progressive muscle-invasive bladder cancer.
    UNASSIGNED: We retrospectively recruited patients, divided them into training and validation cohorts, and gathered patient demographics, pathology data of transurethral bladder tumor resection specimens, imaging findings, and laboratory information. We performed logistic regression analyses, both single-variable and multi-variable, to investigate independent preoperative risk variables and develop a nomogram. Both internal and external validations were conducted to evaluate the predictive performance of this nomogram.
    UNASSIGNED: The training cohort consisted of 144 patients with advanced muscle-invasive bladder cancer, while the validation cohort included 62 individuals. The independent preoperative risk factors identified were tumor pathology grade, platelet count, tumor size on imaging, and lymph node size, which were utilized to develop the nomogram. The model demonstrated high predictive accuracy, as evidenced by the area under the receiver operating characteristic curve values of 0.898 and 0.843 for the primary and external validation cohorts, respectively. Calibration curves and decision curve analysis showed a good performance of the nomogram in both cohorts, indicating its high clinical applicability.
    UNASSIGNED: A nomogram for preoperative prediction of lymph node metastasis in patients with advanced muscle-invasive bladder cancer was successfully developed; its accuracy, reliability, and clinical value were demonstrated. This new tool would facilitate better clinical decisions regarding whether to perform complete lymph node dissection in cases of radical cystectomy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    髓样肉瘤(MS)是一种罕见的髓外肿瘤,具有进展为急性髓细胞性白血病(AML)的高风险。MS患者通常接受AML方案治疗。然而,由于缺乏临床特异性,MS经常被误诊。携带肿瘤蛋白p53(TP53)突变和复杂核型的MS患者被认为预后较差。本研究报告1例淋巴结MS伴TP53(V173G)相关的骨髓增生异常综合征(MDS)。该肿块最初被认为是淋巴瘤并被如此治疗。然而,免疫组织化学分析后,显示细胞CD43,髓过氧化物酶和CD117阳性,患者后来被诊断为MS合并MDS。患者在第一周期化疗后完全缓解,显示血小板减少,第二周期化疗后的红细胞和白细胞计数。第三次化疗后,发生粒细胞缺乏症,导致难治性肺炎并最终因呼吸衰竭而死亡。MS与TP53相关的MDS发病率低,预后差,生存时间短。MS临床表现无特异性,易误诊,导致延误诊断和治疗,并最终恶化患者的预后。因此,淋巴结肿大的患者应尽快进行淋巴结活检,并应进行早期治疗以延长生存期。
    Myeloid sarcoma (MS) is a rare extramedullary tumor mass that carries a high risk of progression to acute myeloid leukemia (AML), and patients with MS are commonly treated with the AML regimen. However, MS is frequently misdiagnosed due to its lack of clinical specificity. Patients with MS who harbor tumor protein p53 (TP53) mutations and complex karyotypes are considered to have a poorer prognosis. The present study reports a case of lymph node MS with TP53 (V173G)-related myelodysplastic syndrome (MDS). The mass was first considered to be a lymphoma and treated as such. However, following immunohistochemical analysis, which revealed cells positive for CD43, myeloperoxidase and CD117, the patient was later diagnosed with MS combined with MDS. The patient went into complete remission after the first cycle of chemotherapy, and showed a decrease in platelet, red blood cell and white blood cell counts following the second cycle of chemotherapy. After the third chemotherapy, agranulocytosis occurred, leading to refractory pneumonia and eventually death due to respiratory failure. MS with TP53-related MDS has a low incidence rate, a poor prognosis and a short survival time. The clinical manifestations of MS are non-specific and easy to misdiagnose, leading to delayed diagnosis and treatment, and ultimately worsening the prognosis of the patients. Therefore, a lymph node biopsy should be performed as soon as possible for patients with lymph node enlargement, and early treatment should be carried out to prolong the survival period.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号